Revolutionizing Chronic Pain Treatment: Bux Pain Management Introduces SynchroMed III
Bux Pain Management has recently introduced the SynchroMed III intrathecal drug delivery system, a novel approach to treating chronic pain, cancer pain, and severe spasticity. This system, which received approval from the U.S. Food and Drug Administration (FDA) on October 10, 2023, is a testament to the advancements in pain management therapies. The SynchroMed III system, developed by Medtronic, enhances patient care by improving safety, efficiency, and effectiveness in pain management.
Dr. Anjum Bux, with an impressive 18 years of experience in pain management, has been instrumental in bringing this technology to patients. On December 13, 2023, Dr. Bux became one of the first in the United States to implant the SynchroMed III pump. The initial recipient in Kentucky has experienced significant improvements, highlighting the system's impact on enhancing quality of life.

"The SynchroMed III pump represents a monumental leap forward in our ability to manage chronic pain for patients," Dr. Bux stated. "By delivering medication directly to the pain's source, we can significantly improve the quality of life for our patients with minimal side effects."
The SynchroMed III system stands out as a safe and effective alternative amidst the opioid crisis, offering precise medication delivery with minimal side effects. It is compatible with 1.5T and 3T full-body MRI scans, ensuring patients have access to comprehensive diagnostic capabilities.
Dr. Bux has successfully implanted 20 SynchroMed III pumps and manages around 700 pain pumps overall. His dedication to improving life for those suffering from chronic neck or low back pain is evident, particularly for patients who have tried other treatments without success.
For individuals seeking more information about Bux Pain Management and its range of services, visiting www.buxpainmanagement.com or contacting their office at +1 859-695-2111 to schedule an appointment is recommended.
Bux Pain Management operates from Lexington, Cynthiana, Maysville, and Danville in Kentucky. Under Dr. Anjum Bux's leadership, the practice prioritizes nonsurgical, minimally invasive treatments aimed at enhancing patient well-being.